Crossmark

Letter to the Editor about “Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention”

Crossref DOI link: https://doi.org/10.1007/s00345-024-05106-x

Published Online: 2024-07-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Qiang, Yi

Zhang, Qi

Feng, Yangdongping

Cao, Qiang
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (42267063, 42267063)
License Information

Text and Data Mining valid from 2024-07-10

Version of Record valid from 2024-07-10
More Information

Article History

Received: 2 June 2024

Accepted: 4 June 2024

First Online: 10 July 2024

Declarations

:

: The authors declare no competing interests.

Document is current

Any future updates will be listed below